American Journal of Ophthalmology最新文献

筛选
英文 中文
Gender Differences in Patient-Physician Communication in Ophthalmic Practice, Pre- and Post-Covid 19.
IF 4.1 1区 医学
American Journal of Ophthalmology Pub Date : 2025-03-15 DOI: 10.1016/j.ajo.2025.03.020
Jasmine S Brown, Sunni Mumford, Dominique A Alexis, Ahmara G Ross, Eve J Higginbotham
{"title":"Gender Differences in Patient-Physician Communication in Ophthalmic Practice, Pre- and Post-Covid 19.","authors":"Jasmine S Brown, Sunni Mumford, Dominique A Alexis, Ahmara G Ross, Eve J Higginbotham","doi":"10.1016/j.ajo.2025.03.020","DOIUrl":"https://doi.org/10.1016/j.ajo.2025.03.020","url":null,"abstract":"<p><strong>Purpose: </strong>Physician communication patterns can increase patient satisfaction and adherence to therapy in the primary care setting. This study investigated gender differences in ophthalmologist communication patterns before and after the Covid-19 pandemic.</p><p><strong>Design: </strong>Retrospective cohort study.</p><p><strong>Methods: </strong>Messages sent by ophthalmic patients at Penn Medicine from 2017-2022 were collected. Differences in the number of physician messages sent for a given patient, median response length and response time to patient inquiries and messages were examined based on year and physician gender.</p><p><strong>Results: </strong>Female ophthalmologists sent longer response messages to their patients (median [25<sup>th</sup>, 75<sup>th</sup> percentiles] response length for women vs. men; 672 [492-965] characters vs. 637 [460, 918] characters; P < .0001) and a higher number of response messages per patient compared to their male counterparts (mean [SD] for women vs. men; 5.5 [2.9] vs. 3.0 [1.5]; P = .04). There was an increase in this gender difference in the peri- and post-Covid 19 period (i.e. 2020-2022) (P = .007). Male ophthalmologists sent a higher percentage of same-day responses from 2017-2020 (P < .0001), while female ophthalmologists sent a higher percentage of same-day responses from 2021-2022 (P < .0001). The largest gender difference in same day responses occurred in 2020 (34% for men vs. 30% for women; (P < .0001).</p><p><strong>Conclusions: </strong>Gender differences exist in ophthalmologist communication patterns and the Covid-19 pandemic impacted these differences. Future studies will be helpful in determining the potential association of these specific communication patterns with patient satisfaction assessments, eye health outcomes and physician burnout.</p>","PeriodicalId":7568,"journal":{"name":"American Journal of Ophthalmology","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143646751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Comment on: Multifocal Vitelliform Paravascular Retinopathy (MVPR): A New Disorder in the Vitelliform Spectrum.
IF 4.1 1区 医学
American Journal of Ophthalmology Pub Date : 2025-03-15 DOI: 10.1016/j.ajo.2025.03.018
Weilin Song, David Sarraf
{"title":"Reply to Comment on: Multifocal Vitelliform Paravascular Retinopathy (MVPR): A New Disorder in the Vitelliform Spectrum.","authors":"Weilin Song, David Sarraf","doi":"10.1016/j.ajo.2025.03.018","DOIUrl":"https://doi.org/10.1016/j.ajo.2025.03.018","url":null,"abstract":"","PeriodicalId":7568,"journal":{"name":"American Journal of Ophthalmology","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143646848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to "The Glaucoma Intensive Treatment Study (GITS): A Randomized Controlled Trial Comparing Intensive and Standard Treatment on 5 Years Visual Field Development" [Am J Ophthalmol 2024;266:274-288].
IF 4.1 1区 医学
American Journal of Ophthalmology Pub Date : 2025-03-15 DOI: 10.1016/j.ajo.2025.02.023
Boel Bengtsson, Anders Heijl, Johan Aspberg, Gauti Jóhannesson, Sabina Andersson-Geimer, Christina Lindén
{"title":"Corrigendum to \"The Glaucoma Intensive Treatment Study (GITS): A Randomized Controlled Trial Comparing Intensive and Standard Treatment on 5 Years Visual Field Development\" [Am J Ophthalmol 2024;266:274-288].","authors":"Boel Bengtsson, Anders Heijl, Johan Aspberg, Gauti Jóhannesson, Sabina Andersson-Geimer, Christina Lindén","doi":"10.1016/j.ajo.2025.02.023","DOIUrl":"https://doi.org/10.1016/j.ajo.2025.02.023","url":null,"abstract":"","PeriodicalId":7568,"journal":{"name":"American Journal of Ophthalmology","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143639362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the Global Consensus on Keratoconus and Ectatic Diseases Agreements Reached on Subclinical Keratoconus.
IF 4.1 1区 医学
American Journal of Ophthalmology Pub Date : 2025-03-13 DOI: 10.1016/j.ajo.2025.03.013
J Bradley Randleman, Bianca N Susanna, Bassel Hammoud, Barbara A L Dutra, Giuliano Scarcelli, Marcony R Santhiago, William J Dupps, Douglas D Koch
{"title":"Evaluating the Global Consensus on Keratoconus and Ectatic Diseases Agreements Reached on Subclinical Keratoconus.","authors":"J Bradley Randleman, Bianca N Susanna, Bassel Hammoud, Barbara A L Dutra, Giuliano Scarcelli, Marcony R Santhiago, William J Dupps, Douglas D Koch","doi":"10.1016/j.ajo.2025.03.013","DOIUrl":"https://doi.org/10.1016/j.ajo.2025.03.013","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the consensus agreements reached in the Global Consensus on Keratoconus and Ectatic Diseases project for subclinical keratoconus, specifically that posterior corneal elevation abnormalities must be present to diagnose mild or subclinical keratoconus.</p><p><strong>Design: </strong>Literature Review METHODS: Database review (PubMed) was performed on January 2, 2024, to identify studies evaluating the ability of posterior corneal surface metrics to identify subclinical keratoconus using the following search terms: posterior corneal elevation; keratoconus screening; corneal ectasia; subclinical keratoconus; keratoconus suspect; and asymmetric keratoconus. Articles were included for final analysis if they evaluated the ability of the posterior corneal surface to identify subclinical keratoconus compared to anterior corneal surface and/or thickness metrics and reported area under the receiver operating curve (AUROC) data for multiple variables to allow for metric comparison. Metrics evaluated in each manuscript were categorized as anterior surface, thickness, or posterior surface. The relative discriminative performance of anterior surface (A), thickness (T), posterior surface (P), and the multimetric D score (D) metrics were evaluated based on AUROC, sensitivity, and specificity in differentiating subclinical keratoconus from normal controls were evaluated.</p><p><strong>Results: </strong>There were 29 articles identified that met the inclusion criteria and were evaluated. In intra-study comparison, anterior surface metrics (37.9%) and thickness metrics (39.2%) performed best at differentiating subclinical keratoconus from normal corneas, while only 4 out of 29 studies (13.8%) reported posterior metrics outperforming all metrics. In the subgroup analysis including the multimetric D score (n=15), anterior surface metrics performed best (33.3%), followed by the D score (26.7%). In this D subgroup, no paper reported superior posterior metric performance.</p><p><strong>Conclusions: </strong>In aggregate, posterior corneal surface metrics performed worse than anterior corneal and thickness metrics in differentiating subclinical keratoconic eyes from normal controls. These results demonstrate a lack of evidence to support the consensus claim that posterior elevation abnormalities must be present to diagnose subclinical keratoconus.</p>","PeriodicalId":7568,"journal":{"name":"American Journal of Ophthalmology","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143633349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiologic study of pediatric uveitis and its ophthalmic complications using the Korean National Health Insurance Claim Database.
IF 4.1 1区 医学
American Journal of Ophthalmology Pub Date : 2025-03-13 DOI: 10.1016/j.ajo.2025.03.019
Eun Hee Hong, Jiyeong Kim, Min Ho Kang, Sung Who Park, Anh Ngoc Tram Tran, Irmak Karaca, Amir Akhavanrezayat, Chi Mong Christopher Or, Zheng Xian Thng, Albert John Bromeo, Anadi Khatri, Diana Do, Quan Dong Nguyen, Yong Un Shin
{"title":"Epidemiologic study of pediatric uveitis and its ophthalmic complications using the Korean National Health Insurance Claim Database.","authors":"Eun Hee Hong, Jiyeong Kim, Min Ho Kang, Sung Who Park, Anh Ngoc Tram Tran, Irmak Karaca, Amir Akhavanrezayat, Chi Mong Christopher Or, Zheng Xian Thng, Albert John Bromeo, Anadi Khatri, Diana Do, Quan Dong Nguyen, Yong Un Shin","doi":"10.1016/j.ajo.2025.03.019","DOIUrl":"https://doi.org/10.1016/j.ajo.2025.03.019","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the incidence and ophthalmic complications of pediatric uveitis using the Korean National Health Insurance (NHI) Service database.</p><p><strong>Design: </strong>Nationwide population-based longitudinal cohort study.</p><p><strong>Methods: </strong>This study used the NHI database from 2005 to 2021 and included individuals <18 years of age diagnosed with uveitis on at least three separate visits between 2010-2014, with a five-year wash-out period and a seven-year follow-up period. All uveitis cases were classified as either anterior or non-anterior on the basis of the diagnostic code. The occurrence of ophthalmic complications during the follow-up period, and the systemic and socioeconomic associations between pediatric uveitis and its ophthalmic complications were investigated. We obtained the incidence of total, anterior, and non-anterior pediatric uveitis between 2010-2014; the percentage of ophthalmic complications during the follow-up period; and hazard ratios for ophthalmic complications of anterior and non-anterior uveitis.</p><p><strong>Results: </strong>A total of 9,495 cases of pediatric uveitis (8,734 cases with anterior and 761 with non-anterior uveitis) were identified, with an average annual incidence (per 10,000 children) of total, anterior, and non-anterior uveitis being 2.0, 1.8, and 0.2, respectively. The most common complications were glaucoma or presumed ocular hypertension, macular disease, and amblyopia. Patients with non-anterior uveitis had a significantly higher risk of ophthalmic complications including retinal detachment, cataract, amblyopia, and glaucoma or presumed ocular hypertension than those with anterior uveitis.</p><p><strong>Conclusions: </strong>This nationwide analysis of pediatric uveitis in South Korea revealed an average incidence of 2.0 per 10,000 children, highlighting the higher risks of ophthalmic complications associated with non-anterior uveitis.</p>","PeriodicalId":7568,"journal":{"name":"American Journal of Ophthalmology","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143633348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration.
IF 4.1 1区 医学
American Journal of Ophthalmology Pub Date : 2025-03-13 DOI: 10.1016/j.ajo.2025.03.021
David A Eichenbaum, Nancy Holekamp, Arshad M Khanani, Dante Pieramici, Vrinda Hershberger, Veeral Sheth, Flavia Brunstein, Ling Ma, Yixuan Zou, Vahan B Indjeian, Randall Dere, Mauricio Maia, Joy C Hsu, Simon S Gao, Brian Yaspan, Jeffrey R Willis, Henry Wiley, Phillip Lai, Hao Chen
{"title":"Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration.","authors":"David A Eichenbaum, Nancy Holekamp, Arshad M Khanani, Dante Pieramici, Vrinda Hershberger, Veeral Sheth, Flavia Brunstein, Ling Ma, Yixuan Zou, Vahan B Indjeian, Randall Dere, Mauricio Maia, Joy C Hsu, Simon S Gao, Brian Yaspan, Jeffrey R Willis, Henry Wiley, Phillip Lai, Hao Chen","doi":"10.1016/j.ajo.2025.03.021","DOIUrl":"https://doi.org/10.1016/j.ajo.2025.03.021","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the safety, tolerability, and efficacy of intravitreal injection of galegenimab, an anti-HtrA1 FAb, in patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).</p><p><strong>Design: </strong>Phase 2, single-masked, randomized clinical trial.</p><p><strong>Methods: </strong>Eligible GA patients with BCVA letter scores of ≥ 24 letters and baseline GA lesion size 2.54∼25.4 mm<sup>2</sup> in the study eye were enrolled. Patients were randomized 2:1:2 to receive 20 mg galegenimab every 4 (Q4W) or 8 weeks (Q8W), or sham Q4/8W. The primary endpoint was mean change in GA area from baseline to Week 72 measured by fundus autofluorescence. A data monitoring committee (DMC) conducted periodic unmasked review of cumulative safety/limited efficacy data of the ongoing study.</p><p><strong>Results: </strong>Among 337 patients who received ≥ 1 dose and have at least one post-baseline GA area measurement, the adjusted mean change in GA area from baseline to Week 72 was 2.67, 2.50, and 2.38 mm<sup>2</sup> for the galegenimab Q4W, galegenimab Q8W, and pooled sham arms, respectively. Differences between the treated and sham groups were not statistically significant. However, the rate of intraocular inflammation was high (7.1%, 16/224 patients) among treated patients. The DMC recommended early termination of the study based on an early benefit/risk analysis.</p><p><strong>Conclusion: </strong>Galegenimab administration did not show a difference in mean change in GA area from baseline to Week 72 compared with sham. Inhibition of HtrA1 with a Fab did not slow down GA progression.</p>","PeriodicalId":7568,"journal":{"name":"American Journal of Ophthalmology","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143633350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Two-Year Clinical and Patient-Reported Outcome Measures Between Acrysof IQ and Clareon PanOptix Multifocal Intraocular Lenses
IF 4.1 1区 医学
American Journal of Ophthalmology Pub Date : 2025-03-12 DOI: 10.1016/j.ajo.2025.03.017
Raimo Tuuminen , Sohee Jeon
{"title":"Comparison of Two-Year Clinical and Patient-Reported Outcome Measures Between Acrysof IQ and Clareon PanOptix Multifocal Intraocular Lenses","authors":"Raimo Tuuminen ,&nbsp;Sohee Jeon","doi":"10.1016/j.ajo.2025.03.017","DOIUrl":"10.1016/j.ajo.2025.03.017","url":null,"abstract":"<div><h3>PURPOSE</h3><div>To compare the 2-year clinical and patient-reported outcome measures of PanOptix multifocal intraocular lenses (MIOLs) based on the lens material.</div></div><div><h3>DESIGN</h3><div>Retrospective matched cohort study.</div></div><div><h3>METHODS</h3><div>A comparison between patients who had undergone bilateral operation with Acrysof IQ versus Clareon PanOptix MIOLs was done by 1-to-1 matching of age, axial length, mean keratometry, and corneal astigmatism. A total of 122 eyes of 122 patients in each group were studied. Main outcome measures analyzed included uncorrected near visual acuity (UNVA) and uncorrected distance visual acuity (UDVA), prediction error in spherical equivalent and postoperative refraction stability, glistening, subsurface nano-glistening (SSNG), Nd:YAG laser posterior capsulotomy rates, the area under the log contrast sensitivity function (AULCSF) under photopic and mesopic conditions, Strehl ratio, and area ratio. Patient-reported outcome measures such as dysphotopsia and modified spectacle-independent Visual Function Index (VF)–14 questionnaire scores were collected at 2 years.</div></div><div><h3>RESULTS</h3><div>Throughout the study period, comparable UNVA, UDVA, and refractive stability were observed between the groups, except for better UNVA among eyes with Clareon than among eyes with Acrysof IQ at 2 years (0.00 ± 0.02 vs 0.02 ± 0.04, <em>P &lt;</em> .001). Clareon implantation resulted in better photopic (1.47 ± 0.19 vs 1.38 ± 0.21 logCWeber units; <em>P &lt;</em> .001), and mesopic (1.16 ± 0.22 vs 1.06 ± 0.19 logCWeber units; <em>P &lt;</em> .001) AULCSF, lower prevalence of glistening (0% vs 88%, <em>P &lt;</em> .001) and SSNG (0% vs 26%, <em>P &lt;</em> .001) and cumulative Nd:YAG laser capsulotomy rates (hazard ratio = 0.632; 95% CI = 0.482-0.830, <em>P &lt;</em> .001) when compared to those with Acrysof IQ. No differences were observed in the incidence of clinically significant glare or halos, but the incidence of starburst (5% vs 16%, <em>P</em> = .002) tended to favor Clareon over Acrysof IQ. Modified VF-14 questionnaire scores were greater for Clareon than Acrysof IQ (93.4 ± 10.3 vs 90.4 ± 13.6 points, <em>P &lt;</em> 0.001). A multivariable regression analysis showed that patient age (beta = –0.394, <em>P &lt;</em> .001; beta = –0.352, <em>P &lt;</em> .001) and glistening grade (beta = –0.163, <em>P = .</em>010; beta = –0.232, <em>P &lt;</em> .001) remained significantly associated with the photopic and mesopic AULCSF, respectively. Furthermore, higher glistening grade (<em>r</em> = –0.144, <em>P = .</em>003; beta = –1.771, <em>P = .</em>001 when age and sex adjusted) were associated with worse modified VF-14 questionnaire scores.</div></div><div><h3>CONCLUSIONS</h3><div>Clareon PanOptix outperformed Acrysof IQ PanOptix in visual quality and spectacle-independent visual function, potentially resulting from a lower prevalence of glistening.</div></div>","PeriodicalId":7568,"journal":{"name":"American Journal of Ophthalmology","volume":"274 ","pages":"Pages 264-275"},"PeriodicalIF":4.1,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143630102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: Multifocal Vitelliform Paravascular Retinopathy (MVPR): A New Disorder in the Vitelliform Spectrum.
IF 4.1 1区 医学
American Journal of Ophthalmology Pub Date : 2025-03-12 DOI: 10.1016/j.ajo.2025.01.026
Camiel J F Boon
{"title":"Comment on: Multifocal Vitelliform Paravascular Retinopathy (MVPR): A New Disorder in the Vitelliform Spectrum.","authors":"Camiel J F Boon","doi":"10.1016/j.ajo.2025.01.026","DOIUrl":"https://doi.org/10.1016/j.ajo.2025.01.026","url":null,"abstract":"","PeriodicalId":7568,"journal":{"name":"American Journal of Ophthalmology","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143630172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Pentosan Polysulfate Maculopathy: Final Outcomes from a 4-Year Prospective Study of Disease Progression after Drug Cessation". 关于 "多硫酸戊聚糖黄斑病变:停药后疾病进展的 4 年前瞻性研究的最终结果 "发表评论。
IF 4.1 1区 医学
American Journal of Ophthalmology Pub Date : 2025-03-12 DOI: 10.1016/j.ajo.2025.01.027
Salih Uzun, Fatma Uzun, Maria Paula Fernandez
{"title":"Comment on \"Pentosan Polysulfate Maculopathy: Final Outcomes from a 4-Year Prospective Study of Disease Progression after Drug Cessation\".","authors":"Salih Uzun, Fatma Uzun, Maria Paula Fernandez","doi":"10.1016/j.ajo.2025.01.027","DOIUrl":"https://doi.org/10.1016/j.ajo.2025.01.027","url":null,"abstract":"","PeriodicalId":7568,"journal":{"name":"American Journal of Ophthalmology","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143630171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unplanned Return to the Operating Room After Cataract Surgery
IF 4.1 1区 医学
American Journal of Ophthalmology Pub Date : 2025-03-11 DOI: 10.1016/j.ajo.2025.03.014
Mallory K. Suazo , Malik Muhammad Hamza Khan , Anam Akhlaq , Muhammad Ali , Oliver D. Schein , Fasika A. Woreta
{"title":"Unplanned Return to the Operating Room After Cataract Surgery","authors":"Mallory K. Suazo ,&nbsp;Malik Muhammad Hamza Khan ,&nbsp;Anam Akhlaq ,&nbsp;Muhammad Ali ,&nbsp;Oliver D. Schein ,&nbsp;Fasika A. Woreta","doi":"10.1016/j.ajo.2025.03.014","DOIUrl":"10.1016/j.ajo.2025.03.014","url":null,"abstract":"<div><h3>PURPOSE</h3><div>To determine the rate of unplanned return to the operating room (OR) within 90 days of cataract surgery and to identify the most common preoperative and intraoperative risk factors.</div></div><div><h3>DESIGN</h3><div>Retrospective case-control study.</div></div><div><h3>SUBJECTS AND CONTROLS</h3><div>Patients aged ≥40 years undergoing cataract surgery at the Wilmer Eye Institute between 2019 and 2022 with at least 90 days of postoperative follow-up were included. Patients with return to the OR for a reason other than a postoperative complication of cataract surgery in the same eye were excluded. For each case, a time-matched control (cataract surgery within 1 month of the case's surgery) was selected using a random number generator.</div></div><div><h3>METHODS</h3><div>The chi-squared test was used for categorical variables, the student's <em>t</em>-test for continuous variables, and the multivariable logistic regression analysis to assess for associated preoperative and intraoperative factors.</div></div><div><h3>MAIN OUTCOME MEASURES</h3><div>The main outcomes included the rate and the most common reasons for unplanned return to the OR as well as the odds ratios of associated preoperative and intraoperative variables.</div></div><div><h3>RESULTS</h3><div>Among 32,480 eyes, 175 eyes (0.54%) had an unplanned return to the OR within 21 ± 21 days of cataract surgery. The most common reason was retained lens fragments in 88 eyes (50%). Patients with an unplanned return to the OR had a worse mean best-corrected visual acuity preoperatively (Snellen equivalent of ∼20/100 for cases vs 20/50 for controls, p-value &lt; .001) and at last follow-up (cases 20/50, controls 20/30, p-value &lt; .001). There were significantly higher odds of an unplanned return to the OR for patients undergoing complex cataract surgery (odds ratio, 1.80; 95% CI, 1.06-3.05) and for patients with prior tamsulosin use (odds ratio, 2.00; 95% CI, 1.09-3.69).</div></div><div><h3>CONCLUSIONS</h3><div>Patients undergoing complex cataract surgery and those with prior tamsulosin use had significantly higher odds of unplanned return to the OR. Monitoring rates of unplanned return to the OR at the institutional and national levels by using national clinical registries or a multicenter study is needed to assist in quality monitoring and to improve patient surgical outcomes.</div></div>","PeriodicalId":7568,"journal":{"name":"American Journal of Ophthalmology","volume":"274 ","pages":"Pages 241-248"},"PeriodicalIF":4.1,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143612956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信